Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins.

Smith JD, Terpening CM, Schmidt SO, Gums JG.

Ann Pharmacother. 2001 Jun;35(6):702-6.

PMID:
11408989
2.

The effect of dietary glutamate on fibromyalgia and irritable bowel symptoms.

Holton KF, Taren DL, Thomson CA, Bennett RM, Jones KD.

Clin Exp Rheumatol. 2012 Nov-Dec;30(6 Suppl 74):10-7. Epub 2012 Dec 14.

PMID:
22766026
3.

Monosodium glutamate and aspartame in perceived pain in fibromyalgia.

Vellisca MY, Latorre JI.

Rheumatol Int. 2014 Jul;34(7):1011-3. doi: 10.1007/s00296-013-2801-5. Epub 2013 Jun 14.

PMID:
23765203
4.

Cognitive and biochemical effects of monosodium glutamate and aspartame, administered individually and in combination in male albino mice.

Abu-Taweel GM, A ZM, Ajarem JS, Ahmad M.

Neurotoxicol Teratol. 2014 Mar-Apr;42:60-7. doi: 10.1016/j.ntt.2014.02.001. Epub 2014 Feb 18.

PMID:
24556450
5.

Hypothalamic morphology following ingestion of aspartame or MSG in the neonatal rodent and primate: a preliminary report.

Reynolds WA, Butler V, Lemkey-Johnston N.

J Toxicol Environ Health. 1976 Nov;2(2):471-80.

PMID:
827619
6.

Effects of chronic dietary exposure to monosodium glutamate on feeding behavior, adiposity, gastrointestinal motility, and cardiovascular function in healthy adult rats.

López-Miranda V, Soto-Montenegro ML, Uranga-Ocio JA, Vera G, Herradón E, González C, Blas C, Martínez-Villaluenga M, López-Pérez AE, Desco M, Abalo R.

Neurogastroenterol Motil. 2015 Nov;27(11):1559-70. doi: 10.1111/nmo.12653. Epub 2015 Aug 24.

PMID:
26303145
7.

Excitotoxicity triggered by neonatal monosodium glutamate treatment and blood-brain barrier function.

Gudiño-Cabrera G, Ureña-Guerrero ME, Rivera-Cervantes MC, Feria-Velasco AI, Beas-Zárate C.

Arch Med Res. 2014 Nov;45(8):653-9. doi: 10.1016/j.arcmed.2014.11.014. Epub 2014 Nov 26. Review.

PMID:
25431840
8.

The significance of excursions above the ADI. Case study: monosodium glutamate.

Walker R.

Regul Toxicol Pharmacol. 1999 Oct;30(2 Pt 2):S119-21. Review.

PMID:
10597625
9.

Aspartame-induced fibromyalgia, an unusual but curable cause of chronic pain.

Ciappuccini R, Ansemant T, Maillefert JF, Tavernier C, Ornetti P.

Clin Exp Rheumatol. 2010 Nov-Dec;28(6 Suppl 63):S131-3. Epub 2010 Dec 22.

PMID:
21176433
10.

Fibromyalgia and nutrition: what news?

Rossi A, Di Lollo AC, Guzzo MP, Giacomelli C, Atzeni F, Bazzichi L, Di Franco M.

Clin Exp Rheumatol. 2015 Jan-Feb;33(1 Suppl 88):S117-25. Epub 2015 Mar 18. Review.

PMID:
25786053
11.

Possible significance of adverse reactions to glutamate in humans.

Reif-Lehrer L.

Fed Proc. 1976 Sep;35(11):2205-11. Review.

PMID:
782921
12.

Monosodium glutamate neonatal treatment as a seizure and excitotoxic model.

López-Pérez SJ, Ureña-Guerrero ME, Morales-Villagrán A.

Brain Res. 2010 Mar 4;1317:246-56. doi: 10.1016/j.brainres.2009.12.054. Epub 2010 Jan 4.

PMID:
20043888
13.

Behavioral deficits in monosodium glutamate rats: specific changes in the structure of feeding behavior.

Stricker-Krongrad A, Burlet C, Beck B.

Life Sci. 1998;62(23):2127-32.

PMID:
9627091
14.

Potential dietary links to central sensitization in fibromyalgia: past reports and future directions.

Holton KF, Kindler LL, Jones KD.

Rheum Dis Clin North Am. 2009 May;35(2):409-20. doi: 10.1016/j.rdc.2009.06.003. Review.

PMID:
19647151
15.
16.

Diphenyl diselenide ameliorates monosodium glutamate induced anxiety-like behavior in rats by modulating hippocampal BDNF-Akt pathway and uptake of GABA and serotonin neurotransmitters.

Rosa SG, Quines CB, Stangherlin EC, Nogueira CW.

Physiol Behav. 2016 Mar 1;155:1-8. doi: 10.1016/j.physbeh.2015.11.038. Epub 2015 Dec 2.

17.

Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease.

Collison KS, Maqbool Z, Saleh SM, Inglis A, Makhoul NJ, Bakheet R, Al-Johi M, Al-Rabiah R, Zaidi MZ, Al-Mohanna FA.

J Lipid Res. 2009 Aug;50(8):1521-37. doi: 10.1194/jlr.M800418-JLR200. Epub 2008 Nov 11.

18.
19.

Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia.

Nakanishi Y, Tsuneyama K, Fujimoto M, Salunga TL, Nomoto K, An JL, Takano Y, Iizuka S, Nagata M, Suzuki W, Shimada T, Aburada M, Nakano M, Selmi C, Gershwin ME.

J Autoimmun. 2008 Feb-Mar;30(1-2):42-50. doi: 10.1016/j.jaut.2007.11.016.

PMID:
18178378
20.

[Transplacental neurotoxic effects of monosodium glutamate on structures and functions of specific brain areas of filial mice].

Gao J, Wu J, Zhao XN, Zhang WN, Zhang YY, Zhang ZX.

Sheng Li Xue Bao. 1994 Feb;46(1):44-51. Chinese.

PMID:
8085168

Supplemental Content

Support Center